Navigation Links
Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure

Most Patients Released From Hospital Within 24-48 Hours

TYLER, Texas, Oct. 18 /PRNewswire/ -- A 32-year-old east Texas man is the first brain tumor patient in the region to benefit from a unique surgical procedure that removes pituitary tumors without making incisions in the skin. Sabatino Bianco, MD, a Trinity Clinic neurosurgeon and the Director of the Trinity Mother Frances Neuroscience Institute, is the first and only neurosurgeon in the region to offer patients an endoscopic transsphenoidal hypophysectomy (ETH). The procedure allows the removal of pituitary tumors through the nasal cavity.


To view the Multimedia News Release, go to:

"This technique originated in Naples, Italy and Pittsburgh and comparatively is offered by very few neurosurgeons in the world," said Dr. Bianco. "In order to perform this operation, a neurosurgeon must go through a long learning curve and have access to specialized endoscopic instrumentation and navigational system technology. The Trinity Mother Frances Neuroscience Institute is proud to be the first in east Texas to offer a complete neuroendoscopic suite and procedures for patients that reduce their pain, recovery time and eliminate travel requirements to distant medical locations."

The procedure eliminates the need for incisions and removal of nasal septum and/or nasal turbinates because the patient's nasal cavity is used to access the pituitary tumor. The pituitary gland is a small, cherry-shaped double structure located near the back of the nasal pathways and attached by a stalk to the base of the brain. It is the gland that affects and controls all hormonal functions in the body.

The procedure is performed using a small fiberoptic-like catheter shaped tool called an endoscope. The four-millimeter endoscope is inserted through a nasal cavity in front of the tumor and the tumor is extracted with special neurosurgical tools. Patients do not require the often uncomfortable nasal packing of conventional procedures and usually go home in 24-48 hours and can return to work in 4-6 weeks. Conventional procedure patients can remain in the hospital for 3-5 days following surgery and miss months of work.

"Conventional microscopic pituitary tumor surgery usually includes an incision under the patient's lip or inside of a nostril," added Dr. Bianco. "The endoscopic transsphenoidal hypophysectomy offers many advantages over the conventional methods, but the greatest advantage for patients is less discomfort and a much faster recovery."

Facts About The Procedure:

-- A variety of pituitary tumors can be removed through a patient's nasal


-- Eliminates the need for incisions in the skin, removal of nasal septum

and/or nasal turbinates.

-- Minimally-invasive, so facial swelling and postoperative pain are

eliminated or reduced.

-- Most patients go home in 24-48 hours.

About Dr. Bianco:

Dr. Bianco attended medical school at the University of Naples Federico II in Naples, Italy. He completed a residency in neurosurgery at the University of Genoa in Liguria, Italy and a fellowship in neuroendoscopy at the University of Pittsburgh. He then completed an additional residency in neurosurgery at Wake Forest Baptist Medical Center in Winston Salem, North Carolina. He is the Director of the Trinity Mother Frances Neuroscience Institute.

About The Trinity Mother Frances Neuroscience Institute:

The Trinity Mother Frances Neuroscience Institute is dedicated to specialized care of patients with brain and spine issues. Specialized equipment included in the Institute includes specialized visual brain mapping capabilities, a technologically advanced neuro microscope not currently in use at any other US Hospital, and a portable CT scanner for use in the TMF Neuro Intensive Care Unit.

For more information on procedures available through the Trinity Mother Frances Neuroscience Institute, call (903) 525-7995 or (877) 233-0018 or visit

SOURCE Trinity Mother Frances Neuroscience Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
3. Allergies are related to mothers menses
4. Mothers with periodontitis may deliver premature babies
5. Chemotherapy Pill Has Fewer Side Effects Than IV
6. Boys reduced mothers life expectancy
7. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
8. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
9. Baby born to SARS mother is healthy
10. Therapy Boosts Chemotherapy Effects
11. Chemotherapy Effective for Bladder Cancer
Post Your Comments:
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: